CD109 downregulation in melanoma attenuates responses to immune checkpoint inhibitors by inducing resistance to tumor-infiltrating lymphocytes during the effector phase
CD109 downregulation in melanoma attenuates responses to immune checkpoint inhibitors by inducing resistance to tumor-infiltrating lymphocytes during the effector phase. // JID Innovations. – URL: https://www.sciencedirect.com/science/article/pii/S2667026726001116?dgcid=rss_sd_all
CD109 downregulation in melanoma attenuates responses to immune checkpoint inhibitors by inducing resistance to tumor-infiltrating lymphocytes during the effector phase. JID Innovations. https://www.sciencedirect.com/science/article/pii/S2667026726001116?dgcid=rss_sd_all
“CD109 downregulation in melanoma attenuates responses to immune checkpoint inhibitors by inducing resistance to tumor-infiltrating lymphocytes during the effector phase.” JID Innovations.
@article{article51382,
title = {CD109 downregulation in melanoma attenuates responses to immune checkpoint inhibitors by inducing resistance to tumor-infiltrating lymphocytes during the effector phase},
journal = {JID Innovations},
url = {https://www.sciencedirect.com/science/article/pii/S2667026726001116?dgcid=rss_sd_all}
}